Pressure BioSciences, Inc. (PBIO)

Pressure BioSciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	0.01	0.08	0	0.13	0.02	0.03
Cash & Short-Term Investments	0.01	0.08	0	0.13	0.02	0.03
Cash Growth	-42.93%	2002.95%	-97.08%	613.65%	-37.42%	-71.27%
Receivables	0.18	0.15	0.3	0.15	0.13	0.23
Inventory	0.54	0.3	0.69	1.15	0.59	0.62
Prepaid Expenses	0.13	0.22	0.26	0.42	0.31	0.21
Total Current Assets	0.87	0.76	1.24	1.86	1.06	1.09
Property, Plant & Equipment	0.65	0.23	0.39	0.51	0.24	0.13
Long-Term Investments	0.06	0.06	0.06	0.06	0.52	0.02
Other Intangible Assets	0.51	-	0.32	0.4	0.49	0.58
Total Assets	6.88	1.05	2.01	2.83	2.3	1.82

Liabilities

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Accounts Payable	2.49	1.32	0.64	0.53	0.77	0.82
Accrued Expenses	12.18	8.36	13.47	9.83	2.46	2.11
Short-Term Debt	3.43	1.91	2.27	1.26	1.3	1.76
Current Portion of Long-Term Debt	25.03	20.68	17.82	12.84	7.55	6.12
Current Portion of Leases	0.21	0.07	0.14	0.13	0.07	0.08
Current Unearned Revenue	0.23	0.23	0.06	0.04	0.05	0.02
Other Current Liabilities	-	1	-	-	6.33	2.95
Total Current Liabilities	43.58	33.58	34.4	24.63	18.52	13.85
Long-Term Debt	0.16	0.16	0.15	0.15	0.53	-
Long-Term Leases	0.36	0.06	0.14	0.26	0.16	-
Long-Term Unearned Revenue	0.01	0	0	0	0.02	0.02
Total Liabilities	44.11	33.8	34.7	25.04	19.22	13.87

Shareholders' Equity

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Common Stock	0.54	0.35	0.14	0.09	0.04	0.03
Additional Paid-In Capital	112.53	100.24	69.01	64.26	50.31	44.26
Retained Earnings	-186.19	-169.03	-133.83	-118.28	-96.47	-78.94
Comprehensive Income & Other	35.89	35.68	32	31.72	29.19	22.6
Total Common Equity	-37.23	-32.75	-32.69	-22.21	-16.92	-12.06
Shareholders' Equity	-37.23	-32.75	-32.69	-22.21	-16.92	-12.06
Total Liabilities & Equity	6.88	1.05	2.01	2.83	2.3	1.82

Additional Metrics

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Total Debt	29.19	22.89	20.53	14.64	9.6	7.96
Net Cash (Debt)	-29.18	-22.8	-20.53	-14.51	-9.58	-7.93
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.78	-0.98	-1.86	-2.19	-2.90	-3.99
Filing Date Shares Outstanding	40.97	34.71	15.87	8.71	4.32	2.77
Total Common Shares Outstanding	54.04	35.37	13.68	9.12	4.17	2.55
Working Capital	-42.7	-32.82	-33.16	-22.77	-17.46	-12.76
Book Value Per Share	-0.69	-0.93	-2.39	-2.44	-4.06	-4.73
Tangible Book Value	-42.52	-32.75	-33	-22.61	-17.41	-12.63
Tangible Book Value Per Share	-0.79	-0.93	-2.41	-2.48	-4.18	-4.96
Machinery	-	0.63	0.62	0.6	0.48	0.48
Leasehold Improvements	-	0.03	0.03	0.03	0.03	0.02

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 30, 2026

Data Sources Report a data error